PEGylated PYY-3-36 (Roche)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePEGylated PYY-3-36 (Roche)
Drug Alias NamePEG-PYY
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuropeptide Y receptor type 2 modulators
TargetsNeuropeptide Y receptor type 2
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoffmann-La Roche Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoffmann-La Roche Inc
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A